Antibody Patenting After Amgen v. Sanofi: U.S. and European Perspectives
November 7, 2018
Webinar
Strafford Publications
As part of Strafford Publications’ webinar series, Finnegan attorneys Amanda Murphy and Jeffrey Jacobstein will examine the patentability requirements in the USPTO and EPO for claiming a broad genus of antibodies. The program will consider best practices on what and how much data should be included in a patent application to support claims of differing scope, the extent to which post-filing data can be relied on to support the claims, and how examiners are being instructed to examine antibody inventions. For more information, or to register, please see Strafford Publications’ website.
